INS and type 1 diabetes mellitus: A recent study showed that CamAPS HX fully CLS (CamDiab, UK) with ultra-rapid insulin lispro (Lyumjev) was safe and improved glycemic control compared to pump and sensor therapy in adults with T1D and suboptimal glycemic control (HbA1c >8%) [87].